Chronic effects of selective endothelin ETA or ETB receptor antagonist on cardiac dysfunction in the J-2-N cardiomyopathic hamsters

被引：0
|
作者：
Nishida, M
Hayashi, T
Ieshima, M
Eshiro, K
Akiyoshi, K
Takaoka, M
Matsumura, Y
机构：
[1] Osaka Univ Pharmaceut Sci, Dept Pharmacol, Osaka 5691094, Japan
[2] Osaka Med Coll, Dept Med 3, Takatsuki, Osaka 5691094, Japan
来源：
JAPANESE JOURNAL OF PHARMACOLOGY | 2002年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P795
引用
收藏
页码：260P / 260P
页数：1
相关论文
共 50 条
  • [31] Short-term hemodynamic effects of BQ-123, a selective endothelin ETA receptor antagonist, in patients with chronic heart failure
    Cowburn, PJ
    Morton, JJ
    McArthur, JD
    MacLean, MR
    Dargie, HJ
    McMurray, JJV
    Cleland, JGF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 250A - 250A
  • [32] Short-term haemodynamic effects of BQ-123, a selective endothelin ETA-receptor antagonist, in chronic heart failure
    Cowburn, PJ
    Cleland, JGF
    McArthur, JD
    MacLean, MR
    McMurray, JJV
    Dargie, HJ
    LANCET, 1998, 352 (9123): : 201 - 202
  • [33] Effects of ETA and ETB receptor blockade on post-ischemic cardiac dysfunction and norepinephrine overflow in isolated rat hearts
    Yamamoto, S
    Matsumoto, N
    Kanazawa, M
    Fujita, M
    Takaoka, M
    Matsumura, Y
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 44 : S394 - S397
  • [34] Effects of the novel selective endothelin ETA receptor antagonist, SB 234551, on the cardiovascular responses to endotoxaemia in conscious rats
    Gardiner, SM
    March, JE
    Kemp, PA
    Bennett, T
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (08) : 1371 - 1377
  • [35] Efficacy of PD 180988, a selective endothelin ETA receptor antagonist, in acute and chronic hypoxia induced pulmonary hypertension.
    Schroeder, RL
    Welch, KM
    Bryant, JW
    Repine, JT
    Cheng, KM
    Keiser, JA
    Haleen, SJ
    FASEB JOURNAL, 1999, 13 (04): : A40 - A40
  • [36] In vitro and in vivo effects of endothelin-1 and YM598, a selective endothelin ETA receptor antagonist, on the lower urinary tract
    Ukai, Masashi
    Yuyama, Hironori
    Fujimori, Akira
    Koakutsu, Akiko
    Sanagi, Masanao
    Itake, Akiyoshi
    Sato, Shuichi
    Sudoh, Katsumi
    Sasamata, Masao
    Miyata, Keiji
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 580 (03) : 394 - 400
  • [37] Selective endothelin ETA and dual ETA/ETB receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease
    Rafnsson, Arnar
    Shemyakin, Alexey
    Pernow, John
    LIFE SCIENCES, 2014, 118 (02) : 435 - 439
  • [38] Hemodynamic and neurohumoral effects of selective endothelin A (ETA) receptor blockade in chronic heart failure -: The heart failure ETA receptor blockade trial (HEAT)
    Lüscher, TF
    Enseleit, F
    Pacher, R
    Mitrovic, V
    Schulze, MR
    Willenbrock, R
    Dietz, R
    Rousson, V
    Hürlimann, D
    Philipp, S
    Notter, T
    Noll, G
    Ruschitzka, F
    CIRCULATION, 2002, 106 (21) : 2666 - 2672
  • [39] Analysis of effects of bosentan (Ro 47-0203), a nonpeptide endothelin ETA/ETB receptor antagonist, in the hind-limb vascular bed of the cat
    Champion, HC
    Estrada, LS
    Estrada, LN
    Filep, JG
    Kadowitz, PJ
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1998, 76 (02) : 141 - 147
  • [40] Effects of a specific endothelin-1A (ETA) receptor antagonist on the development of chronic heart failure (HF) in the dog.
    McConnell, PI
    Wang, W
    Gallagher, K
    Zucker, IH
    FASEB JOURNAL, 1996, 10 (03): : 2485 - 2485
12345